Want to see IN:SHIVALIK full AI Analyst Report?
SHIVALIK Stock Chart & Stats
₹358.75
-₹13.65(-1.86%)
At close: 4:00 PM EST
₹358.75
-₹13.65(-1.86%)
Day’s Range― - ―
52-Week Range₹206.00 - ₹495.40
Previous CloseN/A
Volume18.40K
Average Volume (3M)4.94K
Market Cap
₹5.35B
Enterprise Value₹7.35K
Total Cash (Recent Filing)₹343.68M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)37.5
Beta0.81
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.15%
Share Statistics
EPS (TTM)8.69
Shares Outstanding15,750,365
10 Day Avg. Volume4,520
30 Day Avg. Volume4,938
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.94
P/FCF Ratio-5.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthConsistent top-line expansion indicates resilient demand for the company’s chemical intermediates and specialty products. Sustained growth can support operating scale and strengthen the business over the next several quarters if product volumes and customer demand remain stable.
Conservatively Levered Balance SheetModest leverage and a growing equity base provide financial flexibility for operations, compliance spending and selective investment. Lower debt dependence also reduces balance-sheet risk when chemical-market conditions or input costs become less favorable.
Specialty Chemical B2B PositioningSupplying specialized intermediates to downstream pharmaceutical and agrochemical producers gives the company an established industrial role rather than relying only on consumer demand. Customer-specific specifications and bulk B2B supply can support product relevance and repeat business.
Bears Say
Persistent Negative Cash GenerationNegative operating and free cash flow signals weak conversion of reported business activity into cash. If sustained, working-capital pressure may require reserves or financing to fund operations and investment, limiting flexibility despite the company’s low leverage.
Weaker Profitability And MarginsThe earnings run-rate has weakened even as revenue continued to grow, indicating pressure from product mix, input costs or operating expenses. Inconsistent margins make future profit growth less dependable and could constrain internal funding for expansion.
Lower Returns On EquityDeclining return on equity suggests the expanding capital base is producing less profit efficiently. Unless earnings improve, this can reduce the economic benefit of reinvestment and signal that asset growth is not yet translating into attractive shareholder returns.
Shivalik Rasayan Ltd News
SHIVALIK FAQ
What was Shivalik Rasayan Ltd’s price range in the past 12 months?
Shivalik Rasayan Ltd lowest stock price was ₹206.00 and its highest was ₹495.40 in the past 12 months.
What is Shivalik Rasayan Ltd’s market cap?
Shivalik Rasayan Ltd’s market cap is ₹5.35B.
When is Shivalik Rasayan Ltd’s upcoming earnings report date?
Shivalik Rasayan Ltd’s upcoming earnings report date is Nov 06, 2026 which is in 64 days.
How were Shivalik Rasayan Ltd’s earnings last quarter?
Shivalik Rasayan Ltd released its earnings results on Aug 14, 2026. The company reported ₹2.16 earnings per share for the quarter.
Is Shivalik Rasayan Ltd overvalued?
According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued.
Does Shivalik Rasayan Ltd pay dividends?
Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.15%. See more information on Shivalik Rasayan Ltd dividends here
What is Shivalik Rasayan Ltd’s EPS estimate?
Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shivalik Rasayan Ltd have?
Shivalik Rasayan Ltd has 15,750,365 shares outstanding.
What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?
Shivalik Rasayan Ltd reported an EPS of ₹2.16 in its last earnings report. Following the earnings report the stock price went up 1.718%.
Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?
Currently, no hedge funds are holding shares in IN:SHIVALIK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shivalik Rasayan Ltd
Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.
Technical Analysis
Bodal Chemicals Limited
―
DIC India Limited
―
Mangalam Organics Ltd
―
Poddar Pigments Limited
―
Shankar Lal Rampal Dye-Chem Ltd.
―



